Nicox Grants Kowa Rights To Develop, Commercialize NCX 470
17/7 08:08
(RTTNews) - Nicox SA announced the signing of a new agreement concerning NCX 470 with Kowa, a Japanese company. The agreement, worth up to 191.5 million euros, grants Kowa exclusive rights to develop and commercialize NCX 470, Nicox's nitric oxide-donating bimatoprost eye drop, f...